Jacobs Levy Equity Management’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Jacobs Levy Equity Management’s Portfolio SURF Stock Details SURF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-73,402	Closed	-$104K	–	1081
2019 Q3	$104K	Sell	73,402 -20,698	-22%	-$45.2K	﹤0.01%	889
2019 Q2	$265K	Buy	94,100 +2,500	+3%	+$9.95K	﹤0.01%	830
2019 Q1	$437K	Buy	91,600 +56,466	+161%	+$278K	0.01%	793
2018 Q4	$149K	Buy	35,134 +22,900	+187%	+$177K	﹤0.01%	921
2018 Q3	$134K	Buy	+12,234	New	+$143K	﹤0.01%	957

Other funds holding SURF

AVAI

Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jacobs Levy Equity Management's SURF Position: Q4 2019 in Review

Jacobs Levy Equity Management sold out of Surface Oncology, Inc. Common Stock (SURF) in Q4 2019, closing a stake of 73,402 shares — an estimated $104K sold.

Jacobs Levy Equity Management first reported a position in SURF in Q3 2018 and held it in 5 quarters. The position peaked at $437K in Q1 2019. 34 funds tracked by Wall St. Rank hold SURF as of Q4 2019.

Jacobs Levy Equity Management reported no remaining Surface Oncology, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Jacobs Levy Equity Management sold 73,402 Surface Oncology, Inc. Common Stock shares in Q4 2019, an estimated $104K.
Jacobs Levy Equity Management first reported a position in Surface Oncology, Inc. Common Stock in Q3 2018 and held it in 5 quarters.
Jacobs Levy Equity Management's Surface Oncology, Inc. Common Stock position peaked at $437K in Q1 2019.
34 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q4 2019.

Based on Jacobs Levy Equity Management's 13F filing for Q4 2019, filed 14 Feb 2020.